跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRISPAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TRISPAN
Authorized
STANDARD
TRISPAN
medexus pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5ed85e57980a0f13
Company
medexus pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
5ed85e57980a0f13
Drug Approval Canada Name
TRISPAN
Product Name
TRISPAN
Status
Cancelled Post Market
Status Date
2024-03-11
Original Market Date
2018-10-04
Din
02470632
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intra-Articular , Periarticular , Intrasynovial
Schedule
Prescription
Ahfs
68:04.00
Atc Original
H02AB08 TRIAMCINOLONE
Atc Name
h 02 ab 08
Aig Number
0109565001
Company Name
medexus pharmaceuticals inc.
Company Address
35 Nixon Road, Unit 10, Bolton, Ontario, Canada, L7E 1K1
Active Ingredients
TRIAMCINOLONE HEXACETONIDE
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5ed85e57980a0f13
Type
Standard
Back to Health Canada Approvals